HemoCue Overview

  • Year Founded
  • 1982

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 358

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

HemoCue General Information

Description

Developer medical diagnostic products designed for point-of-care testing on a global scale. The company offers microcuvette diagnostic systems for the measurement and analysis of haemoglobin, glucose, white blood cell count and urine albumin in cases of anaemia, malnutrition, diabetes and infections, thereby helping healthcare institutions in the monitoring, detecting and evaluating symptoms and complications in various health ailments.

Contact Information

Website
www.hemocue.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Parent Company
Corporate Office
  • P.O. Box 1204
  • 262 23 Ängelholm
  • Sweden
+46 077-570 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HemoCue Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HemoCue‘s full profile, request access.

Request a free trial

HemoCue Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer medical diagnostic products designed for point-of-care testing on a global scale. The company offers microcuve
Diagnostic Equipment
Ängelholm, Sweden
358 As of 2022
00000 0000-00-00
000000&0

000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000000000 000000000
Tel Aviv, Israel
00 As of 0000
000.00
00000000000 000.00

00000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000000000 000000000
Abingdon, United Kingdom
00 As of 0000
00000
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HemoCue Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OrSense Formerly VC-backed Tel Aviv, Israel 00 000.00 00000000000 000.00
Sense Biodetection Formerly VC-backed Abingdon, United Kingdom 00 00000 000000&0 00000
Nihon Kohden America Corporation Irvine, CA
Boston Scientific Corporation Marlborough, MA 00000 000.00 000000000 00 000.00
Natus Medical Private Equity-Backed 0000 000.00 000000000000 000.00
You’re viewing 5 of 25 competitors. Get the full list »

HemoCue Executive Team (5)

Name Title Board Seat Contact Info
Kasper Schweitz Ph.D President
Sofie Ljungheimer Chief Financial Officer
You’re viewing 2 of 5 executive team members. Get the full list »

HemoCue Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HemoCue Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore HemoCue‘s full profile, request access.

Request a free trial

HemoCue FAQs

  • When was HemoCue founded?

    HemoCue was founded in 1982.

  • Where is HemoCue headquartered?

    HemoCue is headquartered in Ängelholm, Sweden.

  • What is the size of HemoCue?

    HemoCue has 358 total employees.

  • What industry is HemoCue in?

    HemoCue’s primary industry is Diagnostic Equipment.

  • Is HemoCue a private or public company?

    HemoCue is a Private company.

  • What is the current valuation of HemoCue?

    The current valuation of HemoCue is 00000.

  • What is HemoCue’s current revenue?

    The current revenue for HemoCue is 00000.

  • Who are HemoCue’s investors?

    EQT, Mallinckrodt, and Quest Diagnostics have invested in HemoCue.

  • Who are HemoCue’s competitors?

    OrSense, Sense Biodetection, Nihon Kohden America, Boston Scientific, and Natus Medical are some of the 25 competitors of HemoCue.

  • When was HemoCue acquired?

    HemoCue was acquired on 09-Apr-2013.

  • Who acquired HemoCue?

    HemoCue was acquired by Danaher.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »